Purple Biotech

PPBT
1.5604.70% ( +0.070 )
Closed: Nov 12, 16:00:00 (EDT)

Valuation

Current ValuationThe current P/E ratio is -0.55, above the reasonable range, cheaper than 8.06% of the time in the past 5 years, and the industry ranks 99/257, the industry Median -0.98.

-0.549xP/E
Stock price$1.49Earnings per share$-2.71

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
03774111148

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BAYRYUSBayer
-37.68x--$62.64B
BAYZFUSBayer Aktiengesellschaft
-37.51x--$62.35B
VTRSUSViatris
-39.72x97.55%$24.14B
ELANUSElanco Animal Health
-90.04x183.61%$13.24B
ABVXUSAbivax SA
-17.14x22.99%$7.97B
AXSMUSAxsome Therap
-49.91x29.75%$7.85B
CURLFUSCuraleaf Holdings, Inc.
-328.96x--$6.79B
MANEUSVeraDermics
-63.68x97.44%$6.54B
VREOFUSVIREO GROWTH INC
-97.28x--$6.40B
BLTEUSBelite Bio
-61.35x29.87%$6.28B
LQDAUSLiquidia Tech
-52.47x69.38%$4.94B
DFTXUSDefinium Therapeutics
-13.72x42.85%$4.63B
AMLXUSAmylyx Pharmaceuticals
-25.05x1.59%$4.09B
TARSUSTarsus Pharmaceuticals
-5.39x879.07%$3.78B
ELVNUSEnliven Therapeutics
-33.20x2.84%$3.77B
BHCUSBausch Health
-3.72x511.90%$3.13B
XERSUSXeris Biopharma
-464.63x--$3.02B
MBXUSMBX Biosciences
-19.16x55.43%$2.78B
RGCUSRegencell Bioscience
-229.07x--$2.68B
PHVSUSPharvaris BV
-12.11x10.43%$2.40B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.